the percentage of cd5+ b lymphocytes ranged from 18 % to 51.2 % ( mean 40.3 +/- 11 % ) in iddm patients , whereas in niddm patients and in controls it ranged from 20 % to 25.2 % , ( mean 21.3 +/- 4.1 % ) and from 16 % to 24 % , ( mean 19.3 +/- 1.9 % ) , respectively ( p less than 0.01 vs. niddm patients and vs. controls ) .
C0011854
iddm
C0011849
niddm